BlackRock Fund Advisors’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

BlackRock Fund Advisors’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.58M	Sell	71,310 -281,770	-80%	-$5.27M	﹤0.01%	3192
2016 Q3	$6.53M	Buy	353,080 +13,685	+4%	+$237K	﹤0.01%	2715
2016 Q2	$5.51M	Sell	339,395 -2,920	-0.9%	-$49.2K	﹤0.01%	2740
2016 Q1	$4.83M	Buy	342,315 +77,078	+29%	+$1.04M	﹤0.01%	2763
2015 Q4	$4.52M	Buy	+265,237	New	+$5.17M	﹤0.01%	2887

Other funds holding NDRM

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Fund Advisors's NDRM Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its NeuroDerm Ltd. Ordinary Shares (NDRM) stake by 80% in Q4 2016, selling an estimated $5.27M and leaving 71,310 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

BlackRock Fund Advisors first reported a position in NDRM in Q4 2015 and has held it in 5 quarters since. The position peaked at $6.53M in Q3 2016. 56 funds tracked by Wall St. Rank hold NDRM as of Q4 2016.

BlackRock Fund Advisors held 71,310 shares of NeuroDerm Ltd. Ordinary Shares worth $1.58M as of Q4 2016.
BlackRock Fund Advisors sold 281,770 NeuroDerm Ltd. Ordinary Shares shares in Q4 2016, an estimated $5.27M.
NeuroDerm Ltd. Ordinary Shares made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3192 holding.
BlackRock Fund Advisors first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and has held it in 5 quarters since.
BlackRock Fund Advisors's NeuroDerm Ltd. Ordinary Shares position peaked at $6.53M in Q3 2016.
56 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.